Target Audience

This activity is specifically designed for:

  • Regulators

  • Policy Makers

Learning Objectives

At the end of the course, learners should be able to:

  • Explain trade-offs between accuracy, accessibility, affordability and time-to-result

  • Detail key considerations in balancing risks and benefits


The purpose of this course is to review the findings from the regional and industry consultations we conducted and brainstorm on options that can help bypass bottlenecks, barriers, gaps along the access pathway and reduce duplications of clinical performance studies that delay introduction to use and increase costs. Addressing these issues, the agenda is as follows:

  • Welcome and Introduction

  • Overview of the Accelerating Diagnostics Access Project

  • Highlights from Regional and Industry Consultations

  • Initiatives Synergistic with the Accelerating Diagnostic Access Project

Course Directors

Professor David Heymann, London School of Hygiene & Tropical Medicine, UK

Professor Rosanna Peeling, London School of Hygiene & Tropical Medicine, UK


  • Dr. Noah Fongwen, London School of Hygiene and Tropical Medicine & Africa CDC, UK

  • Scott Chiossi, Chatham House, UK

  • Carlos Gouvea, Latin American Alliance for In Vitro Diagnostic Development (ALADDiV), Brazil

  • Dr. Sidney Yee, DxD Hub, Association of Southeast Asian Nations (ASEAN), Singapore

  • Dr. Jaime Montoya, Council for Health Research and Development, Association of Southeast Asian Nations (ASEAN), Philippines

Learn more!

Add your email to the mailing list to get the latest updates.